Trials & Tribulations How tumor-specific modulation frequencies were discovered October 05, 2018Vol.44 No.37By Boris C. Pasche
FreeTrials & Tribulations Shrinking oncology phase I clinical trials: If the drug is a breakthrough, why would you ever want to utilize the maximally tolerated dose? September 21, 2018Vol.44 No.35By Mark J. Ratain
FreeTrials & Tribulations Searching for Breast Cancer’s “Extreme Survivors” June 08, 2018Vol.44 No.23By Mark Burkard
FreeTrials & Tribulations Why process matters: Considering the ACS colon cancer screening guideline June 01, 2018Vol.44 No.22By David Ransohoff
FreeSatireTrials & Tribulations The imaginary interview(with apologies to Molière, aka Jean-Baptiste Poquelin) May 11, 2018Vol.44 No.19By Derek Raghavan
FreeTrials & Tribulations Learning to “talk less and smile more” while designing a COE strategy worthy of trust April 27, 2018Vol.44 No.17By Erin N. Kobetz
FreeTrials & Tribulations Sales Revenues at the Potential Expense of Patient Safety:The Example of You&i April 13, 2018Vol.44 No.15By Mark J. Ratain, Lisa S. Chen, Allen S. Lichter, R. Donald Harvey, Sonali M. Smith, Leonard B. Saltz, William G. Wierda, Varsha V. Gandhi and Michael J. Keating
FreeTrials & Tribulations The importance of staging lung cancer consistently and correctly worldwide April 06, 2018Vol.44 No.14By Fred R. Hirsch
Trials & Tribulations Rare Cancers, Common Need March 16, 2018Vol.44 No.11By Sandip Patel, Young Kwang Chae and Razelle Kurzrock
FreeTrials & Tribulations A phase III trial seeks to determine whether diet and exercise can cure breast cancer March 02, 2018Vol.44 No.09By Jennifer A. Ligibel
